Literature DB >> 8147642

Cardiac operations in patients with end-stage renal disease.

T K Kaul1, B L Fields, M A Reddy, D R Kahn.   

Abstract

Factors influencing the survival of 35 consecutive patients in end-stage renal disease who required 40 open heart surgical procedures over the past 8 years were studied. The mean age in these patients was 57.7 +/- 3 years (range, 32 to 77 years); 74.3% of the patients were male; and the average duration of hemodialysis was 3.6 +/- 0.6 years. Twenty-nine myocardial procedures (20 of 29 for unstable angina), six valve replacements, and five combined procedures were performed. The actuarial survivals at 1 and 3 months, and at 1, 5, and 8 years were 90%, 85%, 76%, 55%, and 43%, respectively. Based on the results of univariate analysis, the most significant predictor of both early and late mortality was New York Heart Association (NYHA) class IV congestive heart failure. The 5-year survival in the patients 60 years and older was less favorable than that in patients younger than 60 years (45% versus 63%) (p < 0.05). The 5-year survival in the patients in NYHA class IV was only 27%, as compared to 63% in the patients in class II or III (p < 0.001). All survivors have remained free of angina and 19 of the 21 survivors showed an improvement in their NYHA class. Four patients under 40 years of age have subsequently been able to undergo renal transplantation. Overall, these results justify proceeding with an open heart surgical procedure in dialysis patients, when needed, but before the onset of congestive heart failure.

Entities:  

Mesh:

Year:  1994        PMID: 8147642     DOI: 10.1016/0003-4975(94)90569-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Cardiac surgery in patients with end-stage renal disease. Utility of continuous ambulatory peritoneal dialysis.

Authors:  Y Hamada; K Kawachi; T Nakata; S Takano; N Tsunooka; M Sato; Y Watanabe; N Nakano; K Miyauchi; T Kohtani
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-02

2.  Early and long-term results of coronary artery bypass grafting in dialysis patients.

Authors:  S Suehiro; T Shibata; K Hattori; H Hirai; H Fujii; N Aoyama; T Ikuta; M Sakaguchi; H Kinoshita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-11

3.  Outcome after myocardial revascularization and renal transplantation: a 25-year single-institution experience.

Authors:  E R Ferguson; S L Hudson; A G Diethelm; A D Pacifico; L S Dean; W L Holman
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Impact of concomitant cardiac procedure on coronary artery surgery in hemodialysis-dependent patients.

Authors:  Koji Kawahito; Hideo Adachi; Sei-ichiro Murata; Atsushi Yamaguchi; Takashi Ino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-04

5.  Coronary artery bypass grafting for dialysis patients. Effects of cardiopulmonary bypass.

Authors:  Y Nakayama; R Sakata; M Ura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-08

6.  Early results and characteristic problems associated with cardiac surgery in long-term dialysis patients.

Authors:  Y Nakayama; R Sakata; M Ura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-07

Review 7.  Are bioprostheses associated with better outcome than mechanical valves in patients with chronic kidney disease requiring dialysis who undergo valve surgery?

Authors:  Giacomo Bianchi; Marco Solinas; Stefano Bevilacqua; Mattia Glauber
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-01

8.  Surgical Outcome in Hemodialysis Patients with Active-Phase Infective Endocarditis.

Authors:  Tadashi Omoto; Atsushi Aoki; Kazuto Maruta; Tomoaki Masuda
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-03-07       Impact factor: 1.520

9.  Factors associated with early mortality in haemodialysis patients undergoing coronary artery bypass surgery.

Authors:  Deniz Çevirme; Taylan Adademir; Mehmet Aksüt; Tülay Örki; Kamil Cantürk Çakalağaoğlu; Mete Alp; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2016-07-22       Impact factor: 1.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.